Addiction Therapies Inc.
This article was originally published in Start Up
Executive SummaryPositing substance addiction as a memory disease, Addiction Therapies Inc. seeks to address both its chemical and behavioral components. Initially targeting nicotine, alcohol and cocaine addiction, ATI will combine novel therapeutics drugs with proprietary dosing strategies in a platform designed to actively engage addicts in their own recovery.
You may also be interested in...
In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)
We nominated 15 deals in three categories. You picked the winners.